Skip to main content
Caplight Logo









Oncorad Group

Oncorad Group

Private
CasablancaHealthcare & Life Scienceshttps://oncoradgroup.com/

Last Round

Private Equity

May 11, 2023

Total Funding Raised

$45.5M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Oncorad Group is a healthcare company that operates a network of private clinics in Morocco specializing in oncology, radiology, and multidisciplinary medical services.

Sector

Healthcare & Life Sciences

Verticals

Medical Imaging, Telemedicine, Medical Devices, Biotechnology

Business Model

B2C

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

oncologycancer carerobotic surgerymedical imagingradiologytelemedicinegenetic sequencingprivate healthcaremultidisciplinary carediagnostic testingrobot-assisted surgerytelehealthmedical diagnosticshealthcare providerclinical services

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Oncorad Group Comparables

Compare Oncorad Group with similar companies based on industry and business-model similarity.

Oncorad Group comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Oncologie et Diagnostic du Maroc
90%
CIM Santé Group
86%
Akdital
82%

Oncorad Group Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Private EquityMay 11, 2023
Growth EquityApr 23, 2019

Oncorad Group Investors

Notable investors and investment history

Oncorad Group investors
InvestorRounds
CDG Invest GrowthPrivate Equity, Growth Equity
STOAPrivate Equity

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 21, 2026

    Monthly visitors grew 3070% MoM, from 115 to 3.6K.

  • May 21, 2026

    Grew 21% QoQ, from 177 to 214 employees.

Recent news

Latest coverage and updates

  • attends_eventSep 18, 2026

    Oncorad Group attended event European Congress of Robotic Urology Surgery on Sep 9th '26.

Oncorad Group Filings

Explore SEC and related filing metadata, where available.

Oncorad Group filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Oncorad Group's valuation, stock price, and market status.

Is Oncorad Group a public or private company?

Oncorad Group is a private company.

What is the current stock price of Oncorad Group?

Oncorad Group is a private company, so its shares have no public market price. Caplight tracks Oncorad Group's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Oncorad Group worth (valuation)?

Valuation information for Oncorad Group is not publicly available.

Can I buy Oncorad Group stock?

Oncorad Group shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Oncorad Group's last funding round?

Oncorad Group's most recent funding round was Private Equity on May 11, 2023.

Who are the main investors in Oncorad Group?

Key investors in Oncorad Group include CDG Invest Growth.

Will Oncorad Group IPO soon?

No public IPO plans have been announced for Oncorad Group.

How can I track Oncorad Group secondary market activity?

Caplight tracks bids, offers, and trades in Oncorad Group's shares on secondary markets.

Firmographic Details

HeadquartersCasablanca
Employee Range245
Year Founded2000
Last FundingMay 11, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?